Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,452,915
+$864,142 QoQ
Shares Held
17,055
+90.9% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#239
of 477 holders
Holding Since
Dec 2021
9 quarters on record
Voting authority
Sole 61%
Shared 0%
None 39%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Orion Porfolio Solutions, LLC holds $65,856,861 across 60 Biotechnology names. CYTK ranks #17 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,853 | $5,887,740 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
23,454 | $5,651,710 | |
| 3 | RPRX |
Royalty Pharma plc
|
99,319 | $5,568,816 | |
| 4 | INSM |
INSMED Inc
|
35,467 | $3,781,491 | |
| 5 | ARGX |
Argenx SE
|
2,471 | $2,292,519 | |
| 6 | INVA |
Innoviva, Inc.
|
92,707 | $2,105,375 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
24,870 | $1,971,942 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,491 | $1,874,492 |
All Filings in CYTK
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,452,915 | 17,055 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $588,773 | 8,933 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $739,160 | 11,633 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $617,365 | 11,233 | Shares | Sole | 2025-11-12 | |
| 2024-03-31 | $222,108 | 3,168 | Shares | Sole | 2025-07-31 | |
| 2022-12-31 | $222,089 | 4,847 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $236,484 | 4,881 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $293,732 | 7,476 | Shares | Sole | 2022-07-18 | |
| 2021-12-31 | $202,648 | 4,446 | Shares | Sole | 2022-02-08 | |
| No filing history on record for this holder in this stock. | ||||||